Market Leadership in Sight as Eli Lilly’s Oral ...

By Rene Pretorius

April 21, 2025

Summary Eli Lilly's oral GLP-1 medication, orforglipron, has completed a Phas...
NovoCare and the Rise of Direct-to-Consumer Pharmaceutical Access
Semaglutide NAION Risk: EMA Review Initiated Amid Conflicting Evidence